Ambassador Susan C. Schwab

Ambassador Schwab served as U.S. Trade Representative (2006–09) and as deputy (2005–06).

As USTR, she concluded free trade agreements with Peru, Colombia, South Korea and others; and launched the Trans-Pacific Partnership (TPP) negotiations.  She pursued and/or settled trade disputes with various WTO members, including China, Canada, and the EU, and engaged in negotiations at the WTO, APEC and other multilateral institutions.

In academia, she served as dean of the School of Public Policy at the University of Maryland; and as vice chancellor of the University System of Maryland (USM) & CEO of the USM Foundation.  She still teaches classes in international trade.

In the private sector, Schwab was director of corporate business development for Motorola, Inc., where she engaged in M&A and joint venture negotiations in Asia, including in China.

Earlier in government, she served as assistant secretary of Commerce and director-general of the U.S. & Foreign Commercial Service, as a trade staffer and legislative director for Senator John C. Danforth (R-MO), and as a foreign service officer at the US Embassy in Tokyo.  She began her career as an agricultural trade negotiator at USTR.

Ambassador Schwab serves on the boards of Caterpillar, FedEx and Marriott, as well as The Conference Board, Business Council for International Understanding (BCIU), Lee Kuan Yew School of Public Policy, and Signature Theatre of Arlington, VA.  She chairs the board of The National Foreign Trade Council (NFTC).

She holds a BA from Williams College; a Master’s from Stanford University; and a Ph.D. from The George Washington University.

Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox

By Sujai Shivakumar and Anne Pritchett The Trump administration is pursuing lowering prescription drug costs primarily to end what it describes as “global freeloading” and to ensure U.S. patients pay prices comparable to those in other developed nations. The administration argues that while the United States represents less than 5 percent
Read More

Universities, Patents, and the Future of U.S. Competitiveness

By Shruti Sharma and Chris Borges Universities are among the most powerful engines of U.S. innovation, transforming federal research investments into scientific discoveries that underpin economic growth, technological leadership, and national security. Current law, via the Bayh-Dole Act, allows universities to patent inventions and license them to private companies, with royalties
Read More

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More